Show simple item record

dc.contributor.authorNguyen, Thanh N.
dc.contributor.authorKuhn, Anna Luisa
dc.contributor.authorPuri, Ajit S
dc.contributor.authorNogueira, Raul G
dc.date.accessioned2023-01-09T19:38:23Z
dc.date.available2023-01-09T19:38:23Z
dc.date.issued2022-07-28
dc.identifier.citationSVIN COVID-19 Global SAH Registry. Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up. J Neurol Neurosurg Psychiatry. 2022 Jul 28:jnnp-2022-329200. doi: 10.1136/jnnp-2022-329200. Epub ahead of print. PMID: 35902229.en_US
dc.identifier.eissn1468-330X
dc.identifier.doi10.1136/jnnp-2022-329200en_US
dc.identifier.pmid35902229
dc.identifier.urihttp://hdl.handle.net/20.500.14038/51534
dc.descriptionAnna Luisa Kuhn and Ajit S. Puri are collaborators in the SVIN COVID-19 Global SAH Registry. Full author list omitted for brevity. For the full list of authors, see article.en_US
dc.description.abstractBackground: Prior studies indicated a decrease in the incidences of aneurysmal subarachnoid haemorrhage (aSAH) during the early stages of the COVID-19 pandemic. We evaluated differences in the incidence, severity of aSAH presentation, and ruptured aneurysm treatment modality during the first year of the COVID-19 pandemic compared with the preceding year. Methods: We conducted a cross-sectional study including 49 countries and 187 centres. We recorded volumes for COVID-19 hospitalisations, aSAH hospitalisations, Hunt-Hess grade, coiling, clipping and aSAH in-hospital mortality. Diagnoses were identified by International Classification of Diseases, 10th Revision, codes or stroke databases from January 2019 to May 2021. Results: Over the study period, there were 16 247 aSAH admissions, 344 491 COVID-19 admissions, 8300 ruptured aneurysm coiling and 4240 ruptured aneurysm clipping procedures. Declines were observed in aSAH admissions (-6.4% (95% CI -7.0% to -5.8%), p=0.0001) during the first year of the pandemic compared with the prior year, most pronounced in high-volume SAH and high-volume COVID-19 hospitals. There was a trend towards a decline in mild and moderate presentations of subarachnoid haemorrhage (SAH) (mild: -5% (95% CI -5.9% to -4.3%), p=0.06; moderate: -8.3% (95% CI -10.2% to -6.7%), p=0.06) but no difference in higher SAH severity. The ruptured aneurysm clipping rate remained unchanged (30.7% vs 31.2%, p=0.58), whereas ruptured aneurysm coiling increased (53.97% vs 56.5%, p=0.009). There was no difference in aSAH in-hospital mortality rate (19.1% vs 20.1%, p=0.12). Conclusion: During the first year of the pandemic, there was a decrease in aSAH admissions volume, driven by a decrease in mild to moderate presentation of aSAH. There was an increase in the ruptured aneurysm coiling rate but neither change in the ruptured aneurysm clipping rate nor change in aSAH in-hospital mortality. Trial registration number: NCT04934020.en_US
dc.language.isoenen_US
dc.relation.ispartofJournal of Neurology, Neurosurgery and Psychiatryen_US
dc.relation.urlhttps://doi.org/10.1136/jnnp-2022-329200en_US
dc.rights© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.en_US
dc.subjectCEREBROVASCULAR DISEASEen_US
dc.subjectCOVID-19en_US
dc.subjectSUBARACHNOID HAEMORRHAGEen_US
dc.titleGlobal impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-upen_US
dc.typeJournal Articleen_US
dc.source.journaltitleJournal of neurology, neurosurgery, and psychiatry
dc.source.countryEngland
dc.identifier.journalJournal of neurology, neurosurgery, and psychiatry
dc.contributor.departmentRadiologyen_US


This item appears in the following Collection(s)

Show simple item record